NDC 0169-3003-01 - Novolin R
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0169-3003
- Requested NDC
- 0169-3003-01
- Package NDCs from labels
- 0169-3003-01, 0169-3003-15, 0169-3003-12, 0169-3003-25
- Manufacturer
- Novo Nordisk
- Effective date
- 2022-11-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Novolin R - Novo Nordisk | Novo Nordisk | 2022-11-23 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0169-3003-01 | NovolinR | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 19 | |
| 0169-3003-12 | NovolinR | 3 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 3 | 19 | |
| 0169-3003-15 | NovolinR | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 19 | |
| 0169-3003-25 | NovolinR | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0169-3003-01 | ML - Milliliter | 0169-3003 | 476b3f63-aa36-4fed-9ed4-21549f6e3b10 | 1 | 2021-04-08 |
| 0169-3003-12 | ML - Milliliter | 0169-3003 | 4b0b8f92-b40a-4627-9199-59fd02f0cf98 | 1 | 2022-06-06 |
| 0169-3003-15 | ML - Milliliter | 0169-3003 | 95639287-ef66-4d48-9d5f-cb16b204833a | 1 | 2020-01-03 |
| 0169-3003-25 | ML - Milliliter | 0169-3003 | 653bc94f-b955-47ac-830e-17376b766640 | 1 | 2020-01-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| INSULIN HUMAN | ACTIVE INGREDIENT | 1Y17CTI5SR | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| INSULIN HUMAN | ACTIVE MOIETY | 1Y17CTI5SR | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| METACRESOL | INACTIVE INGREDIENT | GGO4Y809LO | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 | |
| ZINC CHLORIDE | INACTIVE INGREDIENT | 86Q357L16B | NOVOLIN R (HUMAN INSULIN) INJECTION, SOLUTION [NOVO NORDISK] | 12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 022dd494-cb3c-4fa7-be99-4c38fabdc612 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | 5e97c4d2-e41d-5bb6-e053-2a91aa0a3163 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | CVS Pharmacy | 94e4a6f3-43d0-b2a5-e053-2a95a90aa115 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f3bc-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rite Aid Corporation | 5da2ea79-f37a-b82b-e053-2a91aa0af0af | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | DSC Laboratories Inc. | a381838b-d1ae-11c5-e053-2a95a90a7bcb | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | 90a4d385-d548-420b-91d2-54d5e819fcce | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | CVS Pharmacy | 3a59c4a9-5f86-406a-e054-00144ff8d46c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Cardinal Health | 7e7e9366-af1e-e0ff-e053-2a91aa0a9487 | 2025-10-24 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Cardinal Health | c2b02afc-5a8a-2a25-e053-2a95a90ae45c | 2025-10-24 | Warnings | PDC6A3C0OX |
| Signature Care Hemorrhoidal Cream (with applicator) | PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, GLYCERIN, PETROLATUM | BETTER LIVING BRANDS, LLC | b026a386-5e38-52ed-e053-2a95a90a6b0e | 2025-10-24 | Warnings | PDC6A3C0OX |
| Lemon Glycerine Swabsticks | GLYCERINE | PHOENIX HEALTHCARE SOLUTIONS, LLC | 436919f7-14cd-4318-9388-b3e1cbec176b | 2025-10-23 | Warnings | PDC6A3C0OX |
| Advanced Eye Relief Dry Eye Rejuvenation | GLYCERIN PROPYLENE GLYCOL | Bausch & Lomb Incorporated | 027969ee-64e4-4b08-bab7-c4cc8ed22f5f | 2025-10-23 | Warnings | PDC6A3C0OX |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Refresh Relieva Preservative Free | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 3481f9b3-5a90-40d3-80f8-81f51cc864be | 2025-10-22 | Warnings | PDC6A3C0OX |
| M-Natal Plus | VITAMIN A, VITAMIN C, VITAMIN D, VITAMIN E, THIAMINE, RIBOFLAVIN, NIACIN, VITAMIN B6, FOLIC ACID, VITAMIN B12, CALCIUM, IRON, ZINC, COPPER | METHOD PHARMACEUTICALS, LLC | 1f8785db-3e65-49d7-b017-b1a65b5ec6b1 | 2025-10-21 | Warnings | J41CSQ7QDS |
| Glycerin | GLYCERIN | Chain Drug Consortium LLC | 4694f05b-d927-4e15-9630-a0a1cddb3cbb | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Amerisource Bergen/Good Neighbor Pharmacy | e6a8914f-cfd9-4c72-abaa-22189bf0faef | 2025-10-16 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 3386fada-6b7f-46fd-e063-6294a90abffc | 2025-10-16 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.